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Background
Since the first antibody tests for human immunodeficiency 
virus (HIV) infection became available, public health orga-
nizations and human rights activists have debated the best 
approach to HIV testing and counselling (HTC).1 At a time 
when there was no effective treatment and HIV-infected indi-
viduals faced widespread discrimination and stigmatization,1 
many argued that HTC was inappropriate because it provided 
little benefit to the individual.1,2 Conversely, others believed 
that testing was the key to promoting a change in behaviour.1,3 
These two concerns framed early debates about HTC.4
Initially, there was general support for a cautious response 
to HTC and HIV infection, although this was considered 
“exceptional” compared with responses to other infectious 
diseases.1,5 For example, in 1987, the World Health Organiza-
tion (WHO) emphasized caution in extending routine HIV 
testing beyond blood donors.1 At that time, standards for HTC, 
which were based on an international consensus reached by 
WHO and other stakeholders, emphasized voluntarism and 
gave rise to the adoption of voluntary counselling and test-
ing.1 This approach consisted of three primary components: 
counselling before and after an HIV test, which included an 
individualized risk-reduction plan based on the test results; 
informed written consent; and confidentiality.1
As evidence emerged that antiretroviral therapy (ART) 
could significantly reduce mother-to-child HIV transmission 
and “alter the clinical course” of HIV infection, the HTC debate 
changed.1,3,6 Clinicians and public health professionals now 
argued that an exceptional approach to HTC was no longer 
appropriate. The view was that HTC should be standard clini-
cal practice in settings where patients present with symptoms 
of an HIV infection and where ART is available.1,2
At first, however, ART was not universally available. In 
2003, only 1% of individuals in need of ART had access to 
treatment and WHO declared a global health emergency.7 This 
declaration gave rise to a series of initiatives for expanding 
access to ART in developing countries, including the 2003 
WHO 3-by-5 initiative and The World Bank’s Multi-Country 
HIV/AIDS Program.7–9 In the same year, increased funding 
for extending treatment became available through the United 
States President’s Emergency Plan for AIDS Relief and the 
Global Fund to Fight AIDS, Tuberculosis and Malaria. In 
addition, the political climate changed and increased access 
to prevention and treatment of HIV infection was endorsed. 
These developments profoundly influenced the debate on 
HTC at a time when fewer than 10% of those infected with 
HIV were aware of their status10 and most were diagnosed at 
the end stage of the disease, when immune suppression made 
ART less effective.11,12 Consequently, voluntary counselling and 
testing was no longer seen as sufficient for enabling people to 
become aware of their HIV status. In the era of ART, alterna-
tive approaches to HTC were required.1,2
One development was the emergence of provider-initiated 
HIV testing and counselling (PITC).1 In 2003, only 52% of 
pregnant women in Botswana knew their HIV status.13 To 
increase the knowledge of HIV status, the government insti-
tuted a policy of “routine” PITC in various clinical settings 
in 2004.14 Similarly, Uganda implemented PITC in referral 
hospitals in 2005 and Zambia implemented it in tuberculosis 
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clinics in 2004.15,16 In 2006, the United 
States Centers for Disease Control and 
Prevention recommended that PITC be 
offered to adults aged 13 to 64 years in 
all health-care settings, with consent be-
ing assumed unless the patient explicitly 
declined.1,17 As treatment was scaled up, 
routine HTC gained traction and several 
countries introduced PITC in clinical 
settings. Early results demonstrated an 
increase in HTC uptake.18–20 With the 
implementation of PITC expanding 
globally, WHO recognized the need for 
guidance. In 2007, WHO and the United 
Nations Programme on HIV/AIDS 
issued a document on PITC in health-
care facilities. The final document was 
an extensive revision of an initial 2006 
draft and took into account concerns 
about coercion, human rights and the 
definition of the word “routine”.1,7
The primary aim of this study was to 
review how policy in African countries 
has changed in response to the growing 
recognition that health-care providers 
should offer more HTC. The rationale 
for focusing on HTC policy in Africa 
was, first, that 68% of the estimated 
34 million people with HIV infections 
worldwide at the end of 2010 resided 
in sub-Saharan Africa, a region with 
only 12% of the global population,21 
and, second, that it was important to 
examine policy responses in settings 
where there was an urgent need to ad-
dress low HTC coverage, for example, 
to prevent mother-to-child HIV trans-
mission or to identify individuals with 
HIV infections who could benefit from 
ART. Additional aims were to investigate 
patients’ perceptions of PITC and their 
experience of the process of PITC, with 
particular reference to informed consent 
and counselling.
Methods
National policy documents, strategies, 
plans, frameworks, guidelines and re-
ports on HIV testing or HIV prevention 
and treatment were identified by search-
ing the WHO Library Information Sys-
tem, Google Scholar and the knowledge 
base repositories of organizations and 
institutions, including the International 
Labour Organization, the United States 
Agency for International Development 
(the AIDSTAR One project), the Uni-
versity of California in San Francisco 
(the HIVInSite knowledge base) and 
Harvard University. The Evidence to Ac-
tion HIV and AIDS Data Hub was also 
searched. Where information was not 
readily available or further clarification 
was required, WHO country represen-
tatives were contacted. In addition, the 
review also considered documents that 
did not focus on HIV prevention alone 
but covered relevant broad issues, such 
as maternal and child health, human 
rights, tuberculosis and opportunistic 
infections.
Identified documents were grouped 
into three categories according to their 
overall objectives:
•	 guidelines, manuals, protocols, legis-
lation and policy;
•	 national strategic plans, strate-
gic frameworks and multisectoral 
frameworks;
•	 other literature, including published 
and unpublished reviews.
The date assumed for the adoption 
of a policy depended largely on the type 
of documents identified and the strength 
of the evidence available, with further 
confirmation being obtained from 
WHO country representatives. Since the 
date of publication of legislation, policy, 
guidelines, manuals and protocols (i.e. 
the first document category) explicitly 
indicated the date on which a policy was 
adopted, this date was used in preference 
to the dates of other documents. When 
these documents were not available, the 
publication date of a strategic plan (i.e. 
the second document category) was 
used. However, when the only docu-
ments identified belonged to the third 
category, the date on which a policy was 
adopted was determined by consultation 
with WHO country representatives.
To obtain information on patients’ 
experiences of and views about PITC, 
we searched the MEDLINE, EMBASE, 
International Bibliography of the Social 
Sciences, PsychINFO and Global Health 
databases for relevant documents pub-
lished in 2000 or later using the follow-
ing terms: provider-initiated, routine, 
diagnostic, opt-out, HIV, human im-
munodeficiency virus, AIDS, acquired 
immune deficiency syndrome, coun-
selling, testing, screening, experience, 
personal experience, opinion, attitude, 
acceptability and informed consent. We 
considered publications from a range of 
disciplines, with a focus on quantitative 
and qualitative studies of PITC. Reports 
of studies were reviewed if the studies: 
(i) involved the routine offer of HTC in 
an African country; (ii) were conducted 
in a clinical setting after HTC had been 
offered to patients or involved patients 
who were recruited in a clinical setting 
and had experience of PITC in that 
clinical setting; or (iii) assessed the ac-
ceptability of PITC to patients or their 
experience with components of the 
PITC process, particularly the acquisi-
tion of informed consent; and (iv) were 
published in English. Data on the ac-
ceptability of PITC and on patients’ 
experiences of PITC were extracted 
separately.
Results
The policies, guidelines or strategic 
plans on PITC from 52 African coun-
tries were reviewed. Documents for 
one country could not be retrieved 
and Western Sahara was not included 
in the review. There was evidence 
that a policy had been adopted by 
42 (79.2%) of 53 countries (Table 1), 
whereas 10 (18.9%) had not adopted a 
policy: Algeria, Angola, Chad, Egypt, 
Libya, Morocco, the Niger, Sao Tome 
and Principe and Tunisia (Fig. 1). 
Documents could not be retrieved 
for the Gambia. A large proportion 
of countries (n = 17; 43.6%) adopted a 
PITC policy between 2005 and 2006, 
whereas 10 (25.6%) adopted a policy 
between 2003 and 2004 and 10 (25.6%), 
including the Comoros, the Congo, the 
Democratic Republic of the Congo and 
South Africa, adopted a policy between 
2007 and 2008. The Central African 
Republic and Equatorial Guinea were 
the last of the 42 countries to adopt 
PITC, in 2009 and 2010, respectively 
(Table 1).
Clinical settings and target 
populations
All 42 countries that adopted a PITC 
policy recommended that pregnant 
women should be covered either in an-
tenatal clinics or in services provided for 
the prevention of mother-to-child HIV 
transmission. In addition, 73.8% of the 
42 countries adopted a policy of univer-
sal PITC, which was defined as offering 
HTC to all patients or adults visiting 
a health-care facility. Documents for 
66.7% of countries recommended PITC 
for either tuberculosis patients or clin-
ics, 45.2% recommended it for patients 
with sexually transmitted infections, 
14.3% for family planning clinics, 7.1% 
for most-at-risk populations and 7.1% 
for individuals attending out-patient 
departments (Table 1).
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Patient’s perspectives and 
experience
The literature search identified over 
2000 publications, of which 11 were 
considered eligible for inclusion in 
the review (Table 2 and  Table 3, avail-
able at: http://www.who.int/bulletin/
volumes/90/9/11-100818). The ma9-
jority were observational studies; 8 
investigated the acceptability of PITC 
to women or their experiences of it in 
antenatal clinics, whereas the remaining 
3 involved tuberculosis patients, women 
attending immunization clinics with 
their infants and patients attending a 
medical emergency unit.
Overall, the large majority of in-
dividuals who received PITC found it 
acceptable (Table 2). For example, in 
Uganda 98.5% of women who were at-
tending an antenatal clinic for the first 
time considered the routine offer of 
HTC during pregnancy “good” or “very 
good”.26 In South Africa, 93% of women 
offered HTC while attending midwife 
obstetric units agreed that all pregnant 
women should be tested for HIV.22 
Among pregnant women who opted for 
HTC in a study from Zimbabwe, 89% 
stated that the routine offer of HTC was 
helpful and empowering and enabled 
women to make an informed decision 
about the prevention of mother-to-child 
HIV transmission and infant feeding.24
In addition, experience of PITC was 
generally regarded as good (Table 3). For 
example, in Zimbabwe, 98% of pregnant 
women stated they were satisfied with 
the information they received on routine 
HTC.24 In South Africa, 52% of pregnant 
women who had been tested for HIV 
felt they had made an informed choice 
and had a positive experience, whereas 
28% felt that their choice had been “less 
clear” and 20% that their voluntariness 
had been compromised.31
Discussion
This review of HTC policy in Africa illus-
trates the changing response to HTC that 
has taken place in the last decade. Before 
WHO issued guidance on PITC in 2007, 
approximately 50% of African coun-
tries had adopted PITC in health-care 
facilities.3,33,34 Subsequently, the number 
of countries that included PITC in their 
HIV policies or strategies increased and, 
by the time of writing, 42 African coun-
tries had elected to recommend PITC in 
health-care facilities, with a large propor-
tion adopting such a policy between 2005 
and 2006. With evidence that ART can 
reduce mother-to-child HIV transmis-
sion, all these countries recommended 
PITC in antenatal clinics. In addition, 
more than half recommended universal 
coverage for all adults and coverage for 
tuberculosis clinics and patients.
Previous studies of the acceptability 
of PITC have used the uptake of test-
ing as an indicator of acceptability.35,36 
Although they provided evidence of the 
feasibility of PITC, these studies did not 
reflect patients’ experiences of or views 
about PITC. Our review of the published 
literature suggests that PITC is generally 
acceptable to patients. Studies reported 
that more than 75% regarded PITC as 
acceptable, particularly in antenatal 
clinics.22 However, findings from studies 
of pregnant women may not be general-
izable to other population groups since 
these women may be more willing to un-
dergo HIV testing because they believe 
it will benefit their children.37 Patients 
in other clinical settings may find PITC 
less acceptable, perhaps because of their 
perceived risk of infection or fear.37 In 
our review, evidence from four studies, 
the majority involving small groups of 
pregnant women, indicated that patients 
were not always aware they had the right 
to decline HTC in antenatal clinics, 
perhaps because of the power balance 
between patients and health-care pro-
viders.29,31 However, studies in other 
regions suggest that women may find the 
routine offer of HTC acceptable because 
it “normalizes” the process of HTC.38
Our review has several limitations. 
It was difficult to retrieve all the docu-
ments required to understand national 
PITC policy fully. Although we con-
Table 1. Provider-initiated HIV testing and counselling in African countries, 2003–2010
Details of PITC policy Countries
No. (%)
Policy adopted
Yes 42 (79.2)
No 10 (18.9)
No information 1 (1.9)
Total 53 (100)
Year policy adopteda
2003 or 2004 10 (25.6)
2005 or 2006 17 (43.6)
2007 or 2008 10 (25.6)
2009 or 2010 2 (5.1)
Total 39 (100)
Document detailing PITC policy
National policy document 35 (83.3)
National strategic plan (excluding national policy documents) 7 (16.7)
Total 42 (100)
Clinical services or settings in which PITC was offeredb
Pregnant women attending antenatal clinics or PMTCT services 42 (100)
All patients or all adults visiting a health-care facility 31 (73.8)
Tuberculosis clinics or patients 28 (66.7)
Sexually transmitted infection clinics or patients 19 (45.2)
Family planning services 6 (14.3)
Inpatients (adult or paediatric) 4 (9.5)
Infants of HIV-positive mothers 4 (9.5)
Most-at-risk populations (e.g. men who have sex with men, injecting drug 
users, female sex workers and commercial sex workers)
3 (7.1)
Outpatient departments 3 (7.1)
Therapeutic feeding centres or children with malnutrition 2 (4.8)
Psychiatric services 1 (2.4)
Male circumcision services 1 (2.4)
HIV, human immunodeficiency virus; PITC, provider-initiated HIV testing and counselling; PMTCT, prevention 
of mother-to-child HIV transmission.
a The date the policy was adopted could not be determined for three countries.
b The total exceeds 100% as some countries adopted PITC for more than one target population.
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tacted WHO country offices, it was not 
possible to obtain information for some 
countries and, for others, the date on 
which policy was adopted was unknown. 
In addition, the ambiguous language 
of some documents made it difficult to 
determine when and in which settings 
policies were adopted. Consequently, 
our data on the years in which PITC 
policies were adopted may be inaccurate. 
We minimized this inaccuracy by asking 
two reviewers to determine indepen-
dently the date of policy adoption using 
the available evidence. Our review of 
patients’ experiences of and views about 
PITC also has several limitations and 
the findings must be interpreted with 
caution. First, our review was subject 
to a language bias and a publication 
bias. Second, the majority of studies 
included took place in antenatal clinics 
and there may be studies from other 
clinical settings that we did not identify. 
Some studies that reported on the ac-
ceptability of PITC included only small 
samples of women and did not involve 
interviews with women who declined an 
offer of HTC.28,31,32 In addition, the stud-
ies included in our review are subject 
to their own limitations: the majority 
were nonrandomized studies and the 
difficulty of reporting and synthesizing 
evidence from nonrandomized studies 
is well documented.39 Moreover, studies 
were subject to acquiescence bias40 and, 
as the questions posed to patients were 
different in each study, it was difficult to 
compare their findings.
In general, the evidence suggests 
that the introduction of PITC in ante-
natal clinics has been associated with 
an increase in HIV testing rates. A 2010 
WHO report on universal access stated 
that the testing rate in eastern and south-
ern Africa rose from 48% in 2008 to 50% 
in 2009.10 Moreover, with the increased 
uptake of HTC and the better access to 
ART that followed from the introduc-
tion of PITC,13 mother-to-child HIV 
transmission has been virtually elimi-
nated in some countries:13,24 in 2009, 
four of the 25 countries with the highest 
HIV disease burden achieved the target 
set by the United Nations General As-
sembly Special Session on HIV/AIDS of 
providing at least 80% of HIV-infected 
pregnant women with ART.10 In addi-
tion, one literature review found that 
the introduction of PITC in antenatal 
clinics contributed to the achievement 
of universal HTC in pregnant women.41 
Moreover, the results of the seven Afri-
can-based studies included in our review 
indicate that implementation of PITC 
led to an increase in the uptake of HTC 
by pregnant women that ranged from 
9.9% in Malawi to 65.6% in Uganda, 
with more than 75% of women accepting 
PITC across all seven studies.41
The implementation of PITC has 
also led to a high rate of HIV testing 
among individuals visiting tuberculo-
sis and sexually transmitted infection 
clinics.15,42–44 A cluster randomized 
trial conducted in tuberculosis clinics 
in South Africa in 2005 found that the 
introduction of opt-out PITC increased 
the uptake of HIV testing by 13.7%, from 
6.5% when HIV testing was carried out 
on an opt-in basis to 20.2% with opt-out 
PITC.45 The 2011 WHO report on global 
tuberculosis control stated that HTC is 
now standard for tuberculosis patients 
in many countries, especially in Africa. 
In 2010, more than 75% of tuberculosis 
patients knew their HIV status in 68 
countries and territories, including 22 
countries in the WHO African Region.46 
Further efforts are still needed globally, 
however, since only 34% of 6.2 million 
tuberculosis patients were aware of their 
HIV status in 2010.
Despite the availability of effective 
therapy and the increase in HIV testing, 
population-based surveys conducted be-
tween 2007 and 2009 in 10 sub-Saharan 
African countries indicated that the me-
dian proportion of people with an HIV 
infection who are aware of their status 
was under 40%.10,47 Moreover, although 
PITC can contribute to increased test-
ing in clinical settings,41 the adoption of 
PITC alone will not achieve universal 
access to HTC. Other approaches that 
enable people not attending health-care 
services to access HIV testing should 
be developed in parallel to ensure that 
access to testing is equitable and that in-
dividuals with HIV infections are diag-
nosed before they become symptomatic. 
In 2011, the HIV Prevention Trials Net-
work study 52 (HPTN052) confirmed 
that ART was effective for preventing the 
transmission of HIV in serodiscordant 
Fig. 1. Adoption of a policy on provider-initiated HIV testing and counselling, Africa, 
2003–2010
2003–2004
2005–2006
2007–2008
2009–2010
Date of PITC policy adoption not identified
PITC policy not adopted
Data not available
Year PITC policy was adopted
HIV, human immunodeficiency virus; PITC, provider-initiated HIV testing and counselling.
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couples.48 There is a rationale, therefore, 
for considering and evaluating house-
hold or community-based testing in 
addition to expanding PITC.49 Data on 
these alternative approaches would help 
identify the most effective and appropri-
ate way of implementing HIV testing 
in specific local contexts, while taking 
into account the resources available and 
social constraints. ■
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摘要
从谨慎到紧迫：非洲的艾滋病检测咨询的演变
目的 描述非洲各国最近在艾滋病毒（HIV）感染的医务人
员主动提供检测咨询（PITC）政策方面的变化，并调查病
人有关PITC的体验和看法。
方法 审查已发表的文献和国家HIV检测的政策、战略框
架、计划和其他有关文件。
结果 在审查的个非洲国家中，有42 个（79.2%）国家已经
采用了PITC政策。在这42 个国家当中，所有国家都推荐
PITC用于预防母婴HIV传播，66.7%的国家推荐用于结核
病诊所和患者，45.2%的国家推荐用于性传播感染诊所。
此外，43.6%的国家在2005 年或2006 年采用PITC。文
献检索确定了11 项有关病人对非洲诊所背景中PITC的体
验和看法的研究。绝大多数人认为PITC是可接受的。然
而，在产前诊所的妇女并不总是知道她们有拒绝接受HIV
检测的权利。
结论 非洲HIV检测咨询的政策和实践已经从强调保密的
谨慎态度转变为具有更大接受程度的常规HIV检测。在诊
所背景中引进PITC有利于在多个这样的背景中增加HIV检
测。大多数患者认为PITC是可以接受的。然而，还需要其
他方法让没到医院看病的人也能被覆盖到。
Résumé
De la prudence à l’urgence: l’évolution des activités de conseil et de dépistage du VIH en Afrique
Objectif Décrire les changements récents dans la politique d’activités 
de conseil et de dépistage à l’initiative du fournisseur (PITC), du virus de 
l’immunodéficience humaine (VIH) dans les pays africains, et enquêter 
sur les expériences et opinions des patients relatives à la PITC.
Méthodes Les publications, ainsi que les politiques nationales, les 
cadres stratégiques, les plans et autres documents pertinents relatifs 
au dépistage du VIH ont été étudiés.
Résultats Sur les pays africains passés en revue, 42 d’entre eux (79.2%) 
avaient adopté une PITC. Sur ces 42 pays, tous recommandaient la PITC 
pour la prévention de la transmission mère-enfant du VIH, 66,7% pour 
les cliniques soignant la tuberculose et les patients affectés par cette 
maladie, et 45,2%, pour les cliniques soignant les infections sexuellement 
transmissibles. En outre, 43,6% des pays avaient adopté la PITC en 
2005 ou 2006. L’examen des publications a permis d’identifier 11 études 
sur les expériences des patients et leur opinion relatives à la PITC dans les 
environnements cliniques en Afrique. La grande majorité considérait la 
PITC comme étant acceptable. Cependant, les femmes en consultations 
prénatales n’étaient pas toujours conscientes du fait qu’elles avaient le 
droit de refuser un dépistage du VIH.
Conclusion La politique et la pratique relatives aux activités de conseil et 
de dépistage du VIH en Afrique sont passées d’une approche prudente, 
mettant l’accent sur la confidentialité, à une plus grande acceptation de 
l’offre systématique de dépistage du VIH. L’introduction de la PITC dans 
les milieux cliniques a contribué à augmenter le dépistage du VIH dans 
plusieurs de ces environnements. La plupart des patients considèrent 
la PITC comme étant acceptable. Toutefois, d’autres approches sont 
nécessaires pour atteindre les personnes qui ne font pas appel aux 
services de santé.
صخلم
ايقيرفإ في يشربلا يعانلما زوعلا سويرف نأشب ةيعوتلاو رابتخلاا روطت :ةحللما ةجالحا لىإ رذلحا نم
 رابتخلااب  ةصالخا  ةسايسلا  في  ةيرخلأا  تايرغتلا  فصو  ضرغلا
 ىودع  نأشب  )PITC(  تامدلخا  يمدقم  نم  ةردابمب  ةيعوتلاو
 يرتحو ةيقيرفلأا نادلبلا في )HIV( يشربلا يعانلما زوعلا سويرف
 يمدقم نم ةردابمب ةيعوتلاو رابتخلاا لوح ضىرلما ءارآو براتج
.تامدلخا
 ةينطولا  تاسايسلاو  ةروشنلما  داوملل  ةعجارم  ءارجإ  مت  ةقيرطلا
 ،ةيجيتاترسلإا رطلأاو ،يشربلا يعانلما زوعلا سويرف تارابتخلا
.ةلصلا تاذ ىرخلأا تادنتسلماو ططلخاو
 اًدلب 42 دمتعا ،ضارعتسلال تعضخ اًيقيرفأ اًدلب ينب نم جئاتنلا
 .تامدلخا يمدقم نم ةردابمب ةيعوتلاو رابتخلاا ةسايس )79.2%(
 ةيعوتلاو  رابتخلااب  اهلك  ينعبرلأاو  يننثلاا  نادلبلا  تصوأ  دقو
 زوعلا  سويرف  لاقتنا  عنلم  كلذو  تامدلخا  يمدقم  نم  ةردابمب
 اهنم % 66.7  ةبسن تصوأو ،لفطلا لىإ ملأا نم يشربلا يعانلما
 %  45.2  ةبسن  تصوأو  ،لسلا  ضىرمو  تادايعل  ةسايسلا  هذبه
 ،كلذ لىع ةولاع .ًايسنج ةلوقنلما ىودعلا تادايع عم اهمادختساب
 يمدقم  نم  ةردابمب  ةيعوتلاو  رابتخلاا  %  43.6  ةبسن  تدمتعا
 داولما  في  ثحبلا  ددحو  .2006  وأ  2005  يماع  في  تامدلخا
 رابتخلاا  نأشب  ضىرلما  ءارآو  براتج  لوح  ةسارد  11  ةروشنلما
 في  تادايعلا  عقاوم  في  تامدلخا  يمدقم  نم  ةردابمب  ةيعوتلاو
 ةردابمب ةيعوتلاو رابتخلاا نأ ةحضاو ةيبلغأ تبرتعا دقو .ايقيرفإ
 تادايع  في  ءاسنلا  نإف  ،كلذ  عمو  .لوبقم  تامدلخا  يمدقم  نم
 رابتخا ءارجإ ضفر في نهقحب ةيارد لىع ًمئاد ّنكي لم لملحا ةياعر
.يشربلا يعانلما زوعلا سويرف
 ةيعوتلاو  رابتخلااب  ةصالخا  ةسرملماو  ةسايسلا  تلوتح  جاتنتسلاا
 دكؤي رذح جنه نم ايقيرفإ في يشربلا يعانلما زوعلا سويرف نأشب
 سويرف رابتخا ءارجلإ يدايتعلاا جهنلل بركأ لوبق لىإ ةيسرلا لىع
 ةردابمب ةيعوتلاو رابتخلاا ميدقت مهاس دقو .يشربلا يعانلما زوعلا
 تارابتخا  ددع ةدايز في تادايعلا  عقاوم في تامدلخا يمدقم نم
 برتعاو  .عقاولما  هذه نم ديدعلا  في يشربلا  يعانلما  زوعلا  سويرف
 تامدلخا يمدقم نم ةردابمب ةيعوتلاو رابتخلاا نأ ضىرلما مظعم
 لىإ  لوصولل  ىرخأ  ج ُهنه  لىإ  ةجاح  كانه  ،كلذ  عمو  .لوبقم  رمأ
.ةيحصلا ةياعرلا تامدخ لىإ نوئجلي لا نيذلا صاخشلأا
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Резюме
От предупреждения к необходимости: развитие консультирования и тестирования на ВИЧ в Африке
Задача Описать недавние изменения в стратегии тестирования 
и консультирования по инфекции вируса иммунодефицита 
человека (ВИЧ), проводимого по инициативе медицинских 
работников (PITC) в африканских странах, и исследовать опыт и 
отношение пациентов к PITC.
Методы Был проведен обзор опубликованной литературы и 
национальных стратегий тестирования на ВИЧ, основных схем 
оперативной деятельности, планов и других соответствующих 
документов.
Результаты Из рассмотренных африканских стран, в 42 (79.2%) 
странах была принята стратегия PITC. Из 42 стран, всеми 
рекомендована PITC для профилактики передачи ВИЧ от матери 
к ребенку, 66,7% рекомендовали стратегию для туберкулезных 
больниц и пациентов, страдающих туберкулезом, и 45,2% - для 
больниц, специализирующихся на инфекционных заболеваниях, 
передающихся половым путем. Кроме того, 43,6% приняли 
PITC в 2005-2006 гг. Благодаря информационному поиску, было 
определено 11 исследований, посвященных опыту и отношению 
пациентов к PITC в условиях клинической практики в Африке. 
Явное большинство считало PITC приемлемой. Впрочем, 
женщины в клиниках дородового наблюдения не во всех случаях 
знали о своем праве на непрохождение теста на ВИЧ.
Вывод Стратегия и практика по консультированию и 
тестированию на ВИЧ в Африке изменилась с продуманного 
подхода, акцентированного на конфиденциальности, к большему 
принятию предложений о тестировании на ВИЧ в целях 
профилактики. Внедрение PITC в клиническую практику привело 
к увеличению числа тестов на ВИЧ в некоторых учреждениях. 
Большинство пациентов считают PITC приемлемой. Однако 
необходимо выработать другие подходы для людей, которые не 
пользуются услугами здравоохранения.
Resumen
De la cautela a la urgencia: La evolución de las pruebas de detección del VIH y el asesoramiento en África
Objetivo Describir los cambios recientes en la estrategia sobre la 
realización de pruebas de detección del virus de la inmunodeficiencia 
humana (VIH) y el asesoramiento emprendidos por los proveedores 
(PITC) en países africanos e investigar las experiencias de los pacientes 
y sus opiniones acerca de la PITC.
Métodos Se llevó a cabo un examen de las publicaciones y de 
estrategias de detección del VIH nacionales, convenios estratégicos, 
planes y otros documentos importantes.
Resultados De los países africanos examinados, 42 (79,2%) había 
adoptado la estrategia PITC. De esos 42, todos recomendaban la 
PITC para prevenir la transmisión maternoinfantil del VIH, el 66,7% la 
recomendaba a las clínicas y pacientes con tuberculosis y el 42,5% a las 
clínicas de tratamiento de infecciones de transmisión sexual. Además, el 
43,6% adoptó la PITC en el año 2005 o 2006. La búsqueda bibliográfica 
identificó 11 estudios sobre las experiencias de los pacientes y sus 
opiniones acerca de la PITC en entornos clínicos de África. Una mayoría 
clara consideró la PICT aceptable. Sin embargo, las mujeres en las clínicas 
de atención prenatal no siempre fueron conscientes de que tenían el 
derecho a rechazar las pruebas de detección del VIH.
Conclusión La estrategia y práctica de las pruebas de detección del VIH 
y el asesoramiento en África han cambiado desde un enfoque cauteloso 
que enfatiza la confidencialidad a una mayor aceptación de la oferta 
sistemática de pruebas de detección del VIH. La introducción de la PITC 
en los entornos clínicos ha contribuido a incrementar el número de 
pruebas de detección del VIH en muchos de esos entornos. La mayoría 
de pacientes considera la PTIC aceptable. No obstante, se necesitan 
otros enfoques para llegar a aquellas personas que no acuden a los 
servicios sanitarios.
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Table 2. Acceptability of provider-initiated HIV testing and counselling, Africa, 1999–2009
Publication 
(Author, year)
Country Primary objective Sample size Population 
group
Acceptability
Etiebet, 200422 South Africa Knowledge, attitude 
and practices survey 
of women receiving 
prenatal or postnatal 
care
264 Women 
attending 
midwife 
obstetric units
(i) 93% agreed that all pregnant women 
should be tested for HIV; (ii) 98% agreed they 
would recommend attendance at a clinic that 
routinely offers HIV testing to a friend or sister
Nakanjako, 200723 Uganda To determine whether 
patients would accept 
a routine offer of HIV 
testing in a medical 
emergency setting
233 Adult patients (i) 99% expressed a need to integrate routine 
HTC into medical care at the emergency unit; 
(ii) 86% believed routine testing would help 
link HIV-positive patients to HIV care services
Chandisarewa, 
200724
Zimbabwe To assess the impact of 
routine ANC testing for 
PMTCT
221 Follow-up 
survey with 
pregnant 
women 
(i) 89.1% stated that offering routine testing 
was helpful as it empowers women to “exercise 
their rights and responsibilities” with regard 
to accessing relevant information and making 
informed choices about PMTCT; (ii) 10.9% 
stated that the offer of routine antenatal 
testing was not helpful
Corneli, 200825 Democratic 
Republic of 
the Congo
To identify an 
acceptable approach 
to HIV testing for 
tuberculosis patients 
based on the views of 
patients and health-
care workers
88 Tuberculosis 
patients
(i) 99% supported the incorporation of HIV 
testing into routine care for tuberculosis 
patients; (ii) 99% expressed the view that 
HIV testing should be offered at the start of 
tuberculosis treatment; (iii) 68% preferred HIV 
testing to be offered by a tuberculosis nurse 
(including 93% of tuberculosis patients who 
were tested in this way); (iv) 24% preferred 
referral to on-site HIV testing; (v) 8% preferred 
referral to a freestanding voluntary HTC site
Byamugisha, 
200926
Uganda To assess attitudes 
towards routine HIV 
testing among new 
ANC attendees
388 First-time ANC 
attendees
Question posed: “Nowadays in this clinic all 
mothers are tested for HIV unless they say no, 
what do you think about this system?” 98.5% 
responded “good” or “very good (helps them 
know their HIV status and thus plan for their 
future and that of their baby)”; 1.5% responded 
“fair”, “bad” or “very bad”
Rollins, 200927 South Africa To determine the 
acceptability and 
feasibility of universal 
HIV testing of 6-week-
old infants attending 
immunization clinics
646 Women with 
infants
(i) Question posed: “How did you feel when 
offered the opportunity of HIV testing?” (for 
infants). Response: 77.9% comfortable; 11% 
surprised; 4.5% frightened; 3.4% shocked; 1.5% 
anxious; 0.3% preferred not to answer; 0.2% 
other; (ii) 89.8% would recommend HTC to 
“others”
Angotti, 201028 Malawi To determine local 
perceptions of routine 
HIV testing and the 
potential consequences
18 (12 from 
an ANC 
attendee 
sample)
Women who 
had been 
offered HTC in 
an ANC and 
accepted
Interviewees made “favourable” comments 
about the routine offer of HTC and generally 
accepted its implementation in an ANC
Larsson, 201129 Uganda To explore women’s 
experiences of, and 
views on, the opt-out 
testing policy and 
associated HIV testing 
in an ANC
18 Pregnant 
women 
attending an 
ANC
Some women viewed the opt-out testing 
policy as positive as it could benefit their child 
and themselves
ANC, antenatal clinic; HIV, human immunodeficiency virus; HTC, HIV testing and counselling; PMTCT, prevention of mother-to-child HIV transmission.
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Table 3. Users’ experiences of provider-initiated HIV testing and counselling, Africa, 1999–2009
Publication 
(Author, year)
Country Primary objective Sample 
size
Population 
group
Experience
Etiebet, 200422 South Africa Knowledge, attitude 
and practices survey 
of women receiving 
prenatal or postnatal 
care
264 Pregnant 
women
(i) 94% were satisfied with the counselling services 
offered to them; (ii) 0.34% felt pressured by nurses 
to accept testing (45% believed that women who 
accepted testing receive better care); (iii) 8% of 
women tested did not remember receiving post-test 
counselling
Chandisarewa, 
200724
Zimbabwe To assess the impact 
of routine ANC 
testing for PMTCT
2011 Exist survey 
with pregnant 
women
98% stated that the information provided by 
counsellors on routine testing had “adequately 
prepared” them for the result
Corneli, 200825 Democratic 
Republic of 
the Congo
To identify an 
acceptable approach 
to HIV testing for 
tuberculosis patients 
based on the views 
of patients and 
health-care workers
88 Tuberculosis 
patients
(i) The majority (71%) felt confident they had the 
right to choose whether or not to be tested; (ii) 29% 
believed it would be difficult to decline a routine 
offer of testing from a nurse and some said this was 
because of the power relationship whereas others felt 
it was because health-care workers know what is best 
for them
Mugore, 200830 Zimbabwe To assess 
understanding of 
a routine offer of 
HTC among women 
attending ANC
146 Pregnant 
women
(i) 95% stated that the information they received 
during group education was sufficient to make 
a decision about whether or not to test for HIV; 
(ii) 94.1% knew their blood was being drawn for HTC; 
(iii) 77.8% of those who declined HTC said it would 
not deter them from seeking ANC at the health facility
Byamugisha, 
200926
Uganda To assess attitudes 
towards routine HIV 
testing among new 
ANC attendees
388 First time ANC 
attendees
(i) 90.2% had a “good” or “very good” experience with 
or opinion of the health education talk, whereas 9.8% 
had a “fair”, “bad” or “very bad” experience; (ii) 86.3% 
had a “good” or “very good” experience with or 
opinion of pretest counselling, whereas 13.7% had a 
“fair”, “bad” or “very bad” experience; (iii) 95.1% had a 
“good” or “very good” experience with or opinion of 
post-test counselling, whereas 4.9% had a “fair”, “bad” 
or “very bad” experience
Groves, 201031 South Africa To evaluate women’s 
experiences with 
HTC
25 Women who 
had been 
tested for HIV 
during their 
most recent 
pregnancy
(i) 52% believed they had clearly consented to testing 
and had a positive experience of group and individual 
education sessions; (ii) 28% said their choice 
was “less clear” and were less positive about the 
education sessions; (iii) 20% felt their choice had been 
compromised (48% of these women expressed the 
view that they experienced less autonomy in deciding 
whether to be tested for HIV)
Angotti, 201028 Malawi To determine local 
perceptions of 
routine HIV testing 
and the potential 
consequences
18  
(12 from 
an ANC 
attendee 
sample)
Women that 
had been 
offered HTC in 
an ANC and 
accepted the 
offer
(i) 22.2% stated that refusing the offer of a test was an 
option and believed that women could still receive 
services if they opted out of testing; (ii) the majority 
who underwent HIV testing stated they were not 
given the option of refusing in the ANC; (iii) HTC was 
considered a precondition for receiving care
Larsson, 201129 Uganda To explore women’s 
experiences of, and 
views on, the opt-
out testing policy 
and associated HIV 
testing in an ANC
18 Pregnant 
women 
attending an 
ANC
(i) Pregnant women recruited from facilities that 
offered testing on site perceived HIV testing as 
compulsory, despite pretest group counselling; 
(ii) generally women thought they could not receive 
any other ANC service if they declined testing; 
(iii) women felt obligated to attempt to persuade 
their partners to attend the ANC for HIV testing and 
felt anxious about asking their male partners to 
participate in couples testing; (iv) women highlighted 
the power asymmetry between themselves and 
health-care providers
Ujiji, 201132 Kenya To identify factors 
associated with 
consent to opt-out 
of HTC
900 Pregnant 
women
(i) 17% understood that HIV testing was optional, 
whereas 83% did not; (ii) when asked: “If you could 
choose to HIV test or not, would you decline?”, 80% 
responded “no” and 20% responded “yes”
ANC, antenatal clinic; HIV, human immunodeficiency virus; HTC, HIV testing and counselling; PMTCT, prevention of mother-to-child HIV transmission.
